Point72 Asset Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-18,200
Closed -$214K 1622
2019
Q2
$214K Buy
+18,200
New +$220K ﹤0.01% 959
2019
Q1
Sell
-450,500
Closed -$4.62M 1337
2018
Q4
$4.62M Buy
+450,500
New +$5.77M 0.02% 571
2018
Q3
Sell
-123,800
Closed -$2.24M 1330
2018
Q2
$1.96M Buy
+123,800
New +$1.88M 0.01% 756
2017
Q4
Sell
-111,146
Closed -$1.36M 1183
2017
Q3
$1.36M Sell
111,146
-158,654
-59% -$1.65M 0.01% 712
2017
Q2
$3.09M Buy
+269,800
New +$4.99M 0.02% 575
2016
Q3
Sell
-47,100
Closed -$1.18M 919
2016
Q2
$1.18M Sell
47,100
-1,106,700
-96% -$29.9M 0.01% 612
2016
Q1
$28.3M Sell
1,153,800
-130,000
-10% -$3.01M 0.22% 122
2015
Q4
$42.4M Buy
1,283,800
+94,100
+8% +$3.18M 0.35% 77
2015
Q3
$39M Buy
1,189,700
+370,300
+45% +$15.7M 0.31% 98
2015
Q2
$43.4M Buy
819,400
+400,167
+95% +$14.6M 0.3% 90
2015
Q1
$12.1M Buy
419,233
+409,933
+4,408% +$11.2M 0.08% 291
2014
Q4
$271K Buy
+9,300
New +$167K ﹤0.01% 631

Other funds holding ALDR